125 related articles for article (PubMed ID: 32193090)
1. Credentialing of vertebral stereotactic ablative body radiotherapy in a multi-centre trial.
Hardcastle N; Kron T; Cook O; Lehmann J; Mitchell PLR; Siva S
Phys Med; 2020 Apr; 72():16-21. PubMed ID: 32193090
[TBL] [Abstract][Full Text] [Related]
2. Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer.
Kron T; Chesson B; Hardcastle N; Crain M; Clements N; Burns M; Ball D
Br J Radiol; 2018 May; 91(1085):20170737. PubMed ID: 29446317
[TBL] [Abstract][Full Text] [Related]
3. On the use of volumetric-modulated arc therapy for single-fraction thoracic vertebral metastases stereotactic body radiosurgery.
Pokhrel D; Sood S; McClinton C; Shen X; Badkul R; Jiang H; Mallory M; Mitchell M; Wang F; Lominska C
Med Dosim; 2017 Spring; 42(1):69-75. PubMed ID: 28129972
[TBL] [Abstract][Full Text] [Related]
4. The challenge of planning vertebral body SBRT: Optimizing target volume coverage.
Hardcastle N; Bignell F; Nelms B; Siva S; Kneebone A; Lao L; Cook O; Harris M; Shakeshaft J
Med Dosim; 2020 Autumn; 45(3):302-307. PubMed ID: 32295749
[TBL] [Abstract][Full Text] [Related]
5. A national dosimetry audit for stereotactic ablative radiotherapy in lung.
Distefano G; Lee J; Jafari S; Gouldstone C; Baker C; Mayles H; Clark CH
Radiother Oncol; 2017 Mar; 122(3):406-410. PubMed ID: 28117079
[TBL] [Abstract][Full Text] [Related]
6. Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01).
Kron T; Pham D; Roxby P; Rolfo A; Foroudi F
Radiother Oncol; 2012 Jun; 103(3):293-8. PubMed ID: 22483676
[TBL] [Abstract][Full Text] [Related]
7. Improvement of off-axis SABR plan verification results by using adapted dose reconstruction algorithms for the Octavius 4D system.
Jeevanandam P; Agnew CE; Irvine DM; McGarry CK
Med Phys; 2018 Apr; 45(4):1738-1747. PubMed ID: 29431850
[TBL] [Abstract][Full Text] [Related]
8. Dose calculation and reporting with a linear Boltzman transport equation solver in vertebral SABR.
Hardcastle N; Hughes J; Siva S; Kron T
Phys Eng Sci Med; 2022 Mar; 45(1):43-48. PubMed ID: 34813052
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery with MLC-defined arcs: Verification of dosimetry, spatial accuracy, and end-to-end tests.
Brezovich IA; Wu X; Popple RA; Covington E; Cardan R; Shen S; Fiveash J; Bredel M; Guthrie B
J Appl Clin Med Phys; 2019 May; 20(5):84-98. PubMed ID: 30977297
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and Performance of ArcCheck and Film using Gamma Criteria in Pre-treatment Quality Assurance of Stereotactic Ablative Radiotherapy.
Ramachandran P; Tajaldeen A; Taylor D; Wanigaratne D; Roozen K; Geso M
J Med Phys; 2017; 42(4):251-257. PubMed ID: 29296040
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the dosimetric leaf gap for use in planning VMAT treatments of spine SABR cases.
Middlebrook ND; Sutherland B; Kairn T
J Appl Clin Med Phys; 2017 Jul; 18(4):133-139. PubMed ID: 28574219
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR).
Nicolae A; Davidson M; Easton H; Helou J; Musunuru H; Loblaw A; Ravi A
Radiat Oncol; 2015 May; 10():122. PubMed ID: 26024900
[TBL] [Abstract][Full Text] [Related]
13. An on-site audit system for dosimetry credentialing of intensity-modulated radiotherapy in Japanese Clinical Oncology Group (JCOG) clinical trials.
Nakamura M; Minemura T; Ishikura S; Nishio T; Narita Y; Nishimura Y
Phys Med; 2016 Aug; 32(8):987-91. PubMed ID: 27402255
[TBL] [Abstract][Full Text] [Related]
14. Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC).
Kim YB; Byun HK; Wee CW; Kim H; Kim S; Yang G; Kim J; Park SJ; Lee JY
BMC Cancer; 2023 Oct; 23(1):1014. PubMed ID: 37864152
[TBL] [Abstract][Full Text] [Related]
15. Results of patient specific quality assurance for patients undergoing stereotactic ablative radiotherapy for lung lesions.
Hardcastle N; Clements N; Chesson B; Aarons Y; Cramb J; Siva S; Wanigaratne DM; Ball D; Kron T
Australas Phys Eng Sci Med; 2014 Mar; 37(1):45-52. PubMed ID: 24399615
[TBL] [Abstract][Full Text] [Related]
16. Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning.
Zhang Y; Chiu T; Dubas J; Tian Z; Lee P; Gu X; Yan Y; Sher D; Timmerman R; Zhao B
Radiat Oncol; 2019 Nov; 14(1):193. PubMed ID: 31684993
[TBL] [Abstract][Full Text] [Related]
17. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
Siva S; Chesson B; Bressel M; Pryor D; Higgs B; Reynolds HM; Hardcastle N; Montgomery R; Vanneste B; Khoo V; Ruben J; Lau E; Hofman MS; De Abreu Lourenco R; Sridharan S; Brook NR; Martin J; Lawrentschuk N; Kron T; Foroudi F
BMC Cancer; 2018 Oct; 18(1):1030. PubMed ID: 30352550
[TBL] [Abstract][Full Text] [Related]
18. Investigating the impact of tumour motion on TomoTherapy stereotactic ablative body radiotherapy (SABR) deliveries on 3-dimensional and 4-dimensional computed tomography.
Hu Y; Archibald-Heeren B; Byrne M; Cai E; Wang Y
Australas Phys Eng Sci Med; 2019 Mar; 42(1):169-179. PubMed ID: 30790140
[TBL] [Abstract][Full Text] [Related]
19. A multicentre 'end to end' dosimetry audit of motion management (4DCT-defined motion envelope) in radiotherapy.
Palmer AL; Nash D; Kearton JR; Jafari SM; Muscat S
Radiother Oncol; 2017 Dec; 125(3):453-458. PubMed ID: 29037776
[TBL] [Abstract][Full Text] [Related]
20. Treatment planning of VMAT and step-and-shoot IMRT delivery techniques for single fraction spine SBRT: An intercomparative dosimetric analysis and phantom-based quality assurance measurements.
Ouyang Z; LaHurd DV; Balagamwala EH; Chao ST; Suh JH; Xia P
J Appl Clin Med Phys; 2020 Jan; 21(1):62-68. PubMed ID: 31821729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
